EXACT SCIENCES CORP (EXAS)

Import this data to Google Sheets with:

=jivedata("EXAS","financials")

Full statements spill as a table. For one cell: =jivedata("EXAS","Revenue") or =jivedata("EXAS","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

EXACT SCIENCES CORP

EXAS • CIK 0001124140

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-204,149	$-1,028,857	$-207,949	$-207,949
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-201,746	$-1,036,161	$-203,888	$-203,888
Operating Income (Loss)	$-215,012	$-1,048,703	$-206,298	$-206,298
Gross Profit	—	$1,918,717	$2,262,755	$2,262,755
Revenue from Contract with Customer, Including Assessed Tax	$2,499,766	$2,758,867	$3,246,990	$3,246,990
Cost of Revenue	$654,248	$840,150	$984,235	$984,235
Operating Expenses	—	$2,976,620	$2,469,053	$2,469,053
Nonoperating Income (Expense)	$13,266	$12,542	$2,410	$2,410
Income Tax Expense (Benefit)	$2,403	$-7,304	$4,061	$4,061
Other Operating Income (Expense), Net	$78,427	$9,200	$0	$0
Weighted Average Number of Shares Outstanding, Basic	180,144,000	184,197,000	188,688,000	188,688,000
Research and Development Expense	$425,882	$431,210	$522,996	$522,996
Selling and Marketing Expense	$727,090	$894,125	$1,050,183	$1,050,183
InterestExpenseNonoperating	—	$27,016	$39,361	$39,361
General and Administrative Expense	$893,204	$781,825	$888,674	$888,674
Asset Impairment Charges	—	$869,460	$7,200	$7,200

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$605,378	$600,889	$955,996	$955,996
Marketable Securities, Current	$172,266	$437,137	$8,715	$8,715
Accounts Receivable, after Allowance for Credit Loss, Current	$203,623	$248,968	$298,653	$298,653
Assets	$6,471,334	$5,928,139	$5,860,629	$5,860,629
Inventory, Net	$127,475	$162,383	$166,201	$166,201
Prepaid Expense and Other Assets, Current	$85,627	$122,046	$126,284	$126,284
Assets, Current	$1,194,369	$1,571,423	$1,555,849	$1,555,849
Property, Plant and Equipment, Net	$698,354	$693,673	$708,664	$708,664
Operating Lease, Right-of-Use Asset	$143,708	$116,952	$122,332	$122,332
Convertible Notes Payable, Noncurrent	$2,314,276	$2,321,067	$2,327,177	$2,327,177
Goodwill	$2,367,120	$2,366,676	$2,368,048	$2,368,048
Other Liabilities, Noncurrent	$335,982	$315,503	$329,317	$329,317
Intangible Assets, Net (Excluding Goodwill)	$1,890,396	$1,009,693	$919,925	$919,925
Operating Lease, Liability, Noncurrent	$161,070	$157,133	$161,931	$161,931
Other Assets, Noncurrent	$177,387	$169,722	$185,811	$185,811
Liabilities	$3,326,029	$3,525,890	$3,459,577	$3,459,577
Accounts Payable, Current	$78,816	$89,572	$175,868	$175,868
Accrued Liabilities, Current	$341,683	$328,292	$416,473	$416,473
Operating Lease, Liability, Current	$29,379	$27,405	$33,591	$33,591
Other Liabilities, Current	$14,823	$37,765	$15,220	$15,220
Convertible Notes Payable, Current	—	$249,153	$0	$0
Liabilities, Current	$514,701	$732,187	$641,152	$641,152
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$1,815	$1,857	$1,909	$1,909
Additional Paid in Capital, Common Stock	$6,611,237	$6,899,368	$7,102,766	$7,102,766
Accumulated Other Comprehensive Income (Loss), Net of Tax	$1,428	$-944	$2,358	$2,358
Retained Earnings (Accumulated Deficit)	$-3,469,175	$-4,498,032	$-4,705,981	$-4,705,981
Stockholders' Equity Attributable to Parent	$3,145,305	$2,402,249	$2,401,052	$2,401,052
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	400,000,000	400,000,000	400,000,000	400,000,000
Common Stock, Shares, Issued	181,364,180	185,616,438	190,802,322	190,802,322

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-204,149	$-1,028,857	$-207,949	$-207,949
Net Cash Provided by (Used in) Operating Activities	$156,119	$210,536	$491,438	$491,438
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$1,321	$-3,294	$891	$891
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$366,885	$-3,039	$349,360	$349,360
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$609,675	$606,636	$955,996	$955,996
Depreciation	—	$119,701	$124,879	$124,879
Payments to Acquire Marketable Securities	$139,854	$465,031	$140,269	$140,269
Equity Securities, FV-NI, Gain (Loss)	$4,098	$-2,713	$3,081	$3,081
Proceeds from Sale and Maturity of Marketable Securities	$363,156	$205,821	$572,277	$572,277
Deferred Income Tax Expense (Benefit)	—	$-10,119	$-1,544	$-1,544
Payments to Acquire Property, Plant, and Equipment	$124,190	$135,989	$134,656	$134,656
Share-based Payment Arrangement, Noncash Expense	$231,312	$214,885	$217,666	$217,666
Amortization of Intangible Assets	$92,160	$95,158	$96,700	$96,700
Payments to Acquire Other Investments	$16,564	$1,731	$55,499	$55,499
Impairment of Long-Lived Assets Held-for-use	$621	$869,460	$7,200	$7,200
Payments to Acquire Businesses, Net of Cash Acquired	$52,413	$0	$0	$0
Research and Development Asset Acquired Other than Through Business Combination, Written-off	—	—	$75,000	$75,000
Payments to Acquire Assets, Investing Activities	$500	$45,000	$75,000	$75,000
Payments for (Proceeds from) Other Investing Activities	$-250	$225	$-297	$-297
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	$-18,044	$-3,346	$26,806	$26,806
Net Cash Provided by (Used in) Investing Activities	$49,679	$-442,155	$195,121	$195,121
Operating Lease, Expense	$27,891	$26,926	$27,040	$27,040
Other Noncash Income (Expense)	—	$519	$-6,896	$-6,896
Increase (Decrease) in Accounts Receivable	$43,416	$46,259	$48,891	$48,891
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	$3,197	$1,651	$1,902	$1,902
Increase (Decrease) in Inventories	$7,690	$34,911	$3,772	$3,772
Proceeds from Stock Plans	$28,344	$31,227	$26,544	$26,544
IncreaseDecreaseInOperatingLeaseLiability	$-26,701	$-25,783	$-28,541	$-28,541
Proceeds from Convertible Debt	$137,976	$266,750	$0	$0
Increase (Decrease) in Accounts Payable	$82,750	$43,538	$214,042	$214,042
Repayments of Accounts Receivable Securitization	—	$50,000	$0	$0
Increase (Decrease) in Other Operating Assets	$11,618	$2,323	$5,794	$5,794
Repayments of Convertible Debt	—	—	$249,172	$249,172
Increase (Decrease) in Other Operating Liabilities	$6,333	$9,726	$-5,219	$-5,219
Payment, Tax Withholding, Share-based Payment Arrangement	—	—	$86,477	$86,477
Payment for Contingent Consideration Liability, Financing Activities	—	—	$19,000	$19,000
Proceeds from (Payments for) Other Financing Activities	$-9,751	$-17,754	$-11,887	$-11,887
Net Cash Provided by (Used in) Financing Activities	$159,766	$231,874	$-338,090	$-338,090
Noncash or Part Noncash Acquisition, Fixed Assets Acquired	$18,505	$13,721	$16,282	$16,282
Stock Issued During Period, Value, Employee Benefit Plan	$35,100	$40,550	$43,943	$43,943
Cash and Cash Equivalents, at Carrying Value	$605,378	$600,889	$955,996	$955,996
Restricted Cash	$4,297	$5,747	$0	$0
Interest Paid, Excluding Capitalized Interest, Operating Activities	$18,776	$27,839	$30,444	$30,444

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("EXAS","financials")

Full statements spill as a table. For one cell: =jivedata("EXAS","Revenue") or =jivedata("EXAS","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.